Yüklüyor......
Experimental Agents for the Treatment of Atherosclerosis: New Directions
Cardiovascular and related metabolic disorders constitute a worldwide health challenge. Atherosclerosis is a chronic inflammatory condition based on both dyslipidemia and inflammation. Therefore, even when dyslipidemia is controlled, the risk of atherosclerosis remains. Among the most efficient infl...
Kaydedildi:
| Yayımlandı: | J Exp Pharmacol |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7901406/ https://ncbi.nlm.nih.gov/pubmed/33633471 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JEP.S265642 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|